Sincerus Pharmaceuticals
Pompano Beach, US · Founded 2015 · Delaware corporation
Founders & leadership
BS
Barret S. MalkinNational Director
JG
Jonathan G. FensterChief Operating Officer
SJ
Spencer J. MalkinChief Executive Officer, Chairman
LJ
Louis Jack StaleyNamed on SEC filing
MG
Michael GleitNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$505.5K disclosed across 1 round · 2019
▶$505.5KraisedMar 2019 · 24 investors · PharmaceuticalsRule 506(b)
▶$505.5KraisedMar 2019 · 24 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Louis Jack StaleyDirector
- Barret S. MalkinExecutive Officer, Director
- Michael GleitDirector
- Jonathan G. FensterExecutive Officer, Director
- Spencer J. MalkinExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $505.5K
- Minimum investment
- $10K
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Sincerus Pharmaceuticals raised?
- Sincerus Pharmaceuticals has disclosed $505.5K raised across 1 round.
- Where is Sincerus Pharmaceuticals headquartered?
- Sincerus Pharmaceuticals is headquartered in Pompano Beach, US.